Pharmanutra S.p.A. (BIT:PHN)

Market Cap	603.08M +24.3%
Revenue (ttm)	127.15M +12.7%
Net Income	17.45M +7.2%
EPS	1.82 +7.9%
Shares Out	9.60M
PE Ratio	34.54
Forward PE	28.08
Dividend	1.00 (1.57%)
Ex-Dividend Date	May 5, 2025

Volume	12,946
Average Volume	25,445
Open	63.60
Previous Close	63.50
Day's Range	62.40 - 63.80
52-Week Range	38.75 - 68.10
Beta	0.28
RSI	56.84
Earnings Date	Mar 13, 2026

About Pharmanutra

Pharmanutra S.p.A., a pharmaceutical and nutraceutical company, researches, designs, develops, and markets nutritional supplements and medical devices in Italy, Europe, the Middle East, South America, Far East, and internationally. The company produces and distributes raw materials and active ingredients for the food, pharmaceutical, and dietary supplement industries. It also offers iron deficiency, inflammation, mineral and vitamin, muscle and joint, sports nutrition, ophthalmic, and night rest products; and medical instrumentation and softwar...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2003
• Employees: 136
• Stock Exchange: Borsa Italiana
• Ticker Symbol: PHN

Financial Performance

In 2024, Pharmanutra's revenue was 116.15 million, an increase of 15.33% compared to the previous year's 100.71 million. Earnings were 16.61 million, an increase of 29.43%.